SS

Suresh Sah

Director Director DIN 08703080
DIN 08703080 First appointment Feb 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2020
Shareholding value Locked Premium profile

About Suresh Sah

Suresh Sah has 6 years in corporate governance. Formerly with 1 company, such as Medrish Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08703080
Primary Designation Director
First Appointment 18 Feb 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Medrish Pharmaceuticals Private Limited U24299BR2020PTC045522
Director 18 Feb 2020 2020 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medrish Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suresh Sah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Sah

Suresh Sah has 6 years in corporate governance. Formerly with 1 company, such as Medrish Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Suresh Sah is associated with 0 companies as a director.

Suresh Sah has expertise in General Business.

Suresh Sah has 6 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available